Timothy A Winowich, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1090 Mountain Valley Rd, Edgewood, NM 87015 Phone: 505-281-1811 |
Kirsten Asbury, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1090 Mountain Valley Rd, Edgewood, NM 87015 Phone: 505-281-1811 |
Mrs. Cecilia Gonzales Morris, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 204 Dinkle Road, Edgewood, NM 87015 Phone: 505-286-7631 |
Anna Catherine Nunn, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 34 Cielo Estrellado Dr, Edgewood, NM 87015 Phone: 505-385-8163 |
Nancy Jean Rawcliffe, MOTR L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1090 Mountain Valley Rd, Edgewood, NM 87015 Phone: 505-281-1811 Fax: 505-281-7704 |
Matthew Paul Sanchez, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1090 Mountain Valley Rd, Edgewood, NM 87015 Phone: 505-281-1811 |
Mr. Andrew H Schlosser, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 38 Wildlife Trl, Edgewood, NM 87015 Phone: 505-265-1711 |
News Archive
Simply180, a full service marketing and advertising agency announced today the beta launch of "Fitdix", a new app it developed that uses smartwatch and artificial intelligence technology to help men end their reliance on pharmaceuticals to boost sexual performance and reduce premature ejaculation.
DSM Biomedical, a global leader in biomedical materials science, today announced the extension of its partnership with CID based on the use of DSM ComfortCoat® Hydrophilic coating technology on the Optima Jet Stent Delivery System and the Fluydo PTCA Balloon Catheter, both with CE marked and launched on the European market last month.
Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced today it has signed an exclusive agreement with Diamyd Medical AB, a Swedish publicly traded company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, to develop and commercialize their GAD65 antigen-based therapy for the treatment and prevention of type 1 diabetes and associated conditions.
An international report published today by Royal Philips reveals that UK patients want better access to healthcare when needed, but don't see a role in helping to ease the burden on the NHS by living healthily.
› Verified 3 days ago